期刊文献+

S/D法及干热法对人凝血因子Ⅷ制品中猪伪狂犬病病毒和猪细小病毒灭活效果的验证 被引量:2

Validation of inactivation effect of porcine pseudorabies virus and porcine parvovirus in human coagulation factor Ⅷ by S/D method and dry heating
原文传递
导出
摘要 目的验证S/D法及干热法对人凝血因子Ⅷ(FⅧ)制品中猪伪狂犬病病毒(pesdorabies virus,PRV)和猪细小病毒(porcine parvovirus,PPV)的灭活效果。方法以PRV和PPV为指示病毒,模拟FⅧ生产工艺中的S/D及干热病毒灭活工艺,采用96孔板微量细胞病变法检测3批FⅧ半成品的残留病毒滴度。结果批号为201203002、2012-04003、201204004 3批FⅧ半成品经(25±1)℃S/D灭活处理15 min后,PRV滴度分别下降≥6.5、≥6.8、≥6.8 lg TCID50/0.1 ml;经(100±2)℃干热灭活30 min后,PPV滴度分别下降4.00、3.92、3.94 lg TCID50/0.1 ml。结论 S/D法及干热法分别对FⅧ制品中PRV和PPV具有良好的灭活效果,本实验为凝血因子类制品的病毒灭活验证工艺的研究奠定了基础。 Objective To verify the inactivation effect of porcine pseudorabies virus(PRV)and porcine parvovirus(PPV)in coagulation factor Ⅷ by S/D method and dry heating.Methods The inactivation procedure during manufacturing of coagulation factor products was simulated using PRV and PPV as indicators.The residual virus titer in three batches of final bulks of FⅧ were determined by micro-CPE on a 96-well microtiter plate.Results The PPV titers in final bulks of FⅧ of Lots 201203002,201204003 and 2012040043 decreased by not less than 6.5,not less than 6.8 and not less than6.8 TCID_(50)/0.1 ml after inactivation by S/D method at(25 ± 1) ℃ for 15 min.However,after dry heating at(100 ±2)℃ for 30 min,the PV titers decreased by 4.00,3.92 and 3.94 Lg TCID_(50)/0.1 ml respectively.Conclusion Both S/D method and dry heating inactivated the PRV and PPV in F Ⅷ effectively,which laid a foundation of further study on verification of virus inactivation procedure of coagulation factor products.
出处 《中国生物制品学杂志》 CAS CSCD 2016年第7期758-760,764,共4页 Chinese Journal of Biologicals
关键词 S/D灭活法 干热灭活法 人凝血因子Ⅷ 猪伪狂犬病病毒 猪细小病毒 S/D method Dry heating Human coagulation factor Ⅷ Porcine pesdorabies virus(PRV) Porcine parvovirus(PPV)
  • 相关文献

参考文献11

  • 1尹惠琼,马玉媛,刘明,王蕊,章金刚.血液制品病毒灭活/清除技术平台的建立与应用[J].中国输血杂志,2010,23(S1):2-2. 被引量:2
  • 2国家食品药品监督管理总局.关于印发《血液制品去除/灭活病毒技术方法及验证指导原则》的通知[S/OL].(2002-05-09)[2015-09-01].http://www.sda.gov.cn/WS01/CL0058/9330.html,2002.
  • 3NISHIZAWA T, OKAMOTO H, KONISHI K, etal. A novel DNA virus (TFV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology [J]. Biochem Biophys Res Commun, 1997, 241 (1): 92-97.
  • 4PRIKHOD'KO G G. Dry-heat sensitivity of human B19 and porcine parvoviruses [J]. Transfusion, 2005, 45 (10): 1692- 1693.
  • 5KIM t S, CHOI Y W, KANG Y, eta!. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor Ⅷ concentrate prepared from human plasma [J]. J Microbiol Biotechnol, 2008, 18 (5): 997-1003.
  • 6杨立宏,岳广智,徐宏山,刘欣玉,王志伟,董关木,贾丽丽.终端干热法灭活凝血因子类制品中细小病毒的工艺验证[J].中国生物制品学杂志,2010,23(9):1018-1020. 被引量:6
  • 7尹惠琼,王蕊,朱凤宣,王建国,章金刚.血液制品病毒灭活/去除技术平台的建立与应用[J].军事医学,2015,39(3):165-168. 被引量:5
  • 8BL?MEL J, RINCKEL L A, LEE D C, et al. Inactivation and neutralization of parvovirus B19 genotype 3 [J]. Transfusion, 2012, 52 (7): 1490-1497.
  • 9赵雄,尹惠琼,章金刚.纤维蛋白原制品病毒灭活方法研究进展[J].中国输血杂志,2008,21(2):141-144. 被引量:13
  • 10侯继峰.血液制品中人细小病毒污染及其灭活进展[C],2012年中国药学大会暨第十二届中国药师周论文集.江苏南京:2012.

二级参考文献40

  • 1章金刚.生物技术产品的病毒安全性[J].中国医药生物技术,2007,2(2):81-84. 被引量:7
  • 2中华人民共和国卫生部.关于转发血液制品去除或灭活病毒处理方法与检测效果指标的函.卫药政发[1994]第264号.
  • 3卫生部司(局)文件.关于下发"血液制品去除或灭活病毒方法及其验证和论证程序"的通知[S].卫药生发[1997]第433号.
  • 4国家药品监督管理局.关于印发《血液制品去除/灭活病毒技术方法及验证指导原则》的通知,国药监注[2002]160号.
  • 5Prikhod'ko GG. Dry-heat sensitivity of human B19 and porcine parvoviruses [J]. Transfusion, 2005, 45 (10) : 1692-1693.
  • 6Kim IS, Choi YW, Kang Y, et al. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor Ⅷ concentrate prepared from human plasma[J]. J Microbiol Biotechnol 2008, 18 (5) : 997-1003.
  • 7Roberts PL, El Hana C, Saldana J. Inactivation of parvovirus B19 and model viruses in factor Ⅷ by dry heat treatment at 80 degree C[J]. Tansfusion, 2006, 46 (9):1648-1650.
  • 8刘隽湘.纤维蛋白(原)制剂[M]//刘隽湘.输血疗法与血液制剂.北京:人民卫生出版社,1996,210-214
  • 9Kheirabadi BS, Acheson EM, Deguzman R, et al. The potential utility of fibrin sealant dressing in repair of vascular injury in swine[J].J Trauma. 2007. 62( 1 ) :94-103
  • 10Schenk WG 3rd, Burks SG, Gagne PJ, et al. Fibrin sealant improves hemostasis in peripheral vascular surgery: a randomized prospective trial[ J]. Ann Surg, 2003, 237(6) :871-876

共引文献20

同被引文献20

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部